References :
1. Stewart DR, Best AF, Williams GM, et al. Neoplasm Risk Among
Individuals With a Pathogenic Germline Variant in DICER1. J Clin
Oncol. 2019;37(8):668-676.
2. Schultz KAP, Williams GM, Kamihara J, et al. DICER1 and Associated
Conditions: Identification of At-risk Individuals and Recommended
Surveillance Strategies. Clin Cancer Res. 2018;24(10):2251-2261.
3. Robertson JC, Jorcyk CL, Oxford JT. DICER1 Syndrome: DICER1 Mutations
in Rare Cancers. Cancers (Basel). 2018;10(5).
4. Kim J, Schultz KAP, Hill DA, Stewart DR. The prevalence of germline
DICER1 pathogenic variation in cancer populations. Mol Genet
Genomic Med. 2019;7(3):e555.
5. de Kock L, Wu MK, Foulkes WD. Ten years of DICER1 mutations:
Provenance, distribution, and associated phenotypes. Hum Mutat.2019;40(11):1939-1953.
6. Schultz KA, Yang J, Doros L, et al. DICER1-pleuropulmonary blastoma
familial tumor predisposition syndrome: a unique constellation of
neoplastic conditions. Pathol Case Rev. 2014;19(2):90-100.
7. Warren M, Hiemenz MC, Schmidt R, et al. Expanding the spectrum of
dicer1-associated sarcomas. Mod Pathol. 2020;33(1):164-174.
8. Schultz KAP, Nelson A, Harris AK, et al. Pleuropulmonary
blastoma-like peritoneal sarcoma: a newly described malignancy
associated with biallelic DICER1 pathogenic variation. Mod
Pathol. 2020;33(10):1922-1929.
9. Nakano Y, Hasegawa D, Stewart DR, et al. Presacral malignant teratoid
neoplasm in association with pathogenic DICER1 variation. Mod
Pathol. 2019;32(12):1744-1750.
10. McCluggage WG, Foulkes WD. DICER1-associated sarcomas: towards a
unified nomenclature. Mod Pathol. 2020.
11. Pancaldi A, Peng L, Rhee DS, et al. DICER1-associated metastatic
abdominopelvic primitive neuroectodermal tumor with an EWSR1
rearrangement in a 16-yr-old female. Cold Spring Harb Mol Case
Stud. 2020;6(5).
12. McCluggage WG, Apellaniz-Ruiz M, Chong AL, et al. Embryonal
Rhabdomyosarcoma of the Ovary and Fallopian Tube: Rare Neoplasms
Associated With Germline and Somatic DICER1 Mutations. Am J Surg
Pathol. 2020;44(6):738-747.
13. de Kock L, Priest JR, Foulkes WD, Alexandrescu S. An update on the
central nervous system manifestations of DICER1 syndrome. Acta
Neuropathol. 2020;139(4):689-701.
14. Apellaniz-Ruiz M, Cullinan N, Grant R, et al. DICER1 screening in 15
paediatric paratesticular sarcomas unveils an unusual DICER1-associated
sarcoma. J Pathol Clin Res. 2020;6(3):185-194.
15. Doros LA, Rossi CT, Yang J, et al. DICER1 mutations in childhood
cystic nephroma and its relationship to DICER1-renal sarcoma. Mod
Pathol. 2014;27(9):1267-1280.
16. Yoon JY, Apellaniz-Ruiz M, Chong AL, et al. The Value of DICER1
Mutation Analysis in ”Subtle” Diagnostically Challenging Embryonal
Rhabdomyosarcomas of the Uterine Cervix. Int J Gynecol Pathol.2020.
17. Doros L, Yang J, Dehner L, et al. DICER1 mutations in embryonal
rhabdomyosarcomas from children with and without familial PPB-tumor
predisposition syndrome. Pediatr Blood Cancer.2012;59(3):558-560.
18. McCluggage WG, Chong AL, de Kock L, Foulkes WD. Somatic tumour
testing establishes that bilateral DICER1-associated ovarian
Sertoli-Leydig cell tumours represent independent primary neoplasms.Histopathology. 2020.
19. Apellaniz-Ruiz M, McCluggage WG, Foulkes WD. DICER1-associated
embryonal rhabdomyosarcoma and adenosarcoma of the gynecologic tract:
Pathology, molecular genetics, and indications for molecular testing.Genes Chromosomes Cancer. 2021;60(3):217-233.
20. de Kock L, Yoon JY, Apellaniz-Ruiz M, et al. Significantly greater
prevalence of DICER1 alterations in uterine embryonal rhabdomyosarcoma
compared to adenosarcoma. Mod Pathol. 2020;33(6):1207-1219.
21. Kamihara J, Paulson V, Breen MA, et al. DICER1-associated central
nervous system sarcoma in children: comprehensive clinicopathologic and
genetic analysis of a newly described rare tumor. Mod Pathol.2020;33(10):1910-1921.
22. Koelsche C, Mynarek M, Schrimpf D, et al. Primary intracranial
spindle cell sarcoma with rhabdomyosarcoma-like features share a highly
distinct methylation profile and DICER1 mutations. Acta
Neuropathol. 2018;136(2):327-337.
23. Mlika M, Anjum F, El Mezni F. Pleuropulmonary Blastoma. In:StatPearls. Treasure Island (FL)2021.
24. Shern JF, Chen L, Chmielecki J, et al. Comprehensive genomic
analysis of rhabdomyosarcoma reveals a landscape of alterations
affecting a common genetic axis in fusion-positive and fusion-negative
tumors. Cancer Discov. 2014;4(2):216-231.
25. Arora K, Riddle ND. Extraskeletal Mesenchymal Chondrosarcoma.Arch Pathol Lab Med. 2018;142(11):1421-1424.
26. Koelsche C, Schrimpf D, Stichel D, et al. Sarcoma classification by
DNA methylation profiling. Nat Commun. 2021;12(1):498.
27. Schultz KA, Harris A, Williams GM, et al. Judicious DICER1 testing
and surveillance imaging facilitates early diagnosis and cure of
pleuropulmonary blastoma. Pediatr Blood Cancer.2014;61(9):1695-1697.